Fundraising Fox
/Companies
Sign in

Microbot Medical Inc.

NASDAQ: MBOT

Braintree, US · Delaware corporation · 1 known investors

Find your way into Microbot Medical Inc.

Sign up to see every warm intro you have to Microbot Medical Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Microbot Medical Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Microbot Medical develops LIBERTY, a single-use, remotely operated endovascular robotic system that lets physicians perform peripheral vascular procedures from a seated position with remote control. The system is aimed at hospitals and interventional physicians seeking to adopt robotic technology for endovascular care.

BiotechHealthtechMedical DevicesRobotics

Founders & leadership

MS
Moshe ShohamFounder
HGHarel Gadot
Harel GadotExecutive
RVRachel Vaknin
Rachel VakninExecutive
SSSimon Sharon
Simon SharonExecutiveSimon Sharon is an Executive Officer at Microbot Medical, which develops LIBERTY, a remotely operated endovascular robotic system for peripheral vascular procedures. He has prior experience in medical device development and managing product teams from conception through commercialization.
JD
Juan Diaz-CartelleExecutiveJuan Diaz-Cartelle is an executive officer at Microbot Medical, which develops LIBERTY, a remotely operated endovascular robotic system for peripheral vascular procedures. He has background and expertise in vascular surgery, endovascular procedures, and surgical device development.
DB
David Ben NaimChief Financial Officer
YH
Yehezkel HimelfarbChief Operating Officer
YB
Yoseph BornsteinNamed on SEC filing

Board

SM
Solomon MayerBoard director
AS
Aileen StockburgerBoard director
TW
Tal WenderowBoard directorFounding Managing Partner at Star51 Capital
PL
Prattipati LaxminarainBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$452.6M disclosed across 7 of 10 rounds · 2016–2025

▶$25.2MraisedSep 2025 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Aileen StockburgerDirector
  • Martin MaddenDirector
  • Rachel VakninExecutive Officer
  • Tal WenderowDirector
  • HAREL GADOTExecutive Officer, Director
  • Prattipati LaxminarainDirector
  • Juan Diaz- CartelleExecutive Officer
  • David WilsonDirector
  • SIMON SHARONExecutive Officer
  • Scott BurellDirector
Offering amount
$25.2M
Amount sold
$25.2M
Sales commissions
$2.1M
Placement agents
H.C. WAINWRIGHT & CO., LLC
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13MraisedFeb 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott BurellDirector
  • Tal WenderowDirector
  • Aileen StockburgerDirector
  • Juan Diaz- CartelleExecutive Officer
  • Martin MaddenDirector
  • David WilsonDirector
  • Rachel VakninExecutive Officer
  • SIMON SHARONExecutive Officer
  • HAREL GADOTExecutive Officer, Director
  • Prattipati LaxminarainDirector
Offering amount
$13M
Amount sold
$13M
Sales commissions
$1M
Placement agents
H.C. Wainwright & Co.
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.6MraisedJan 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Aileen StockburgerDirector
  • Tal WenderowDirector
  • HAREL GADOTExecutive Officer, Director
  • Prattipati LaxminarainDirector
  • Rachel VakninExecutive Officer
  • Scott BurellDirector
  • SIMON SHARONExecutive Officer
  • Martin MaddenDirector
  • David WilsonDirector
  • Juan Diaz-CartelleExecutive Officer
Offering amount
$8.6M
Amount sold
$8.6M
Sales commissions
$688K
Placement agents
H.C. Wainwright & Co.
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedJan 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rachel VakninExecutive Officer
  • Scott BurellDirector
  • HAREL GADOTExecutive Officer, Director
  • Martin MaddenDirector
  • Juan Diaz-CartelleExecutive Officer
  • SIMON SHARONExecutive Officer
  • Prattipati LaxminarainDirector
  • Aileen StockburgerDirector
  • David WilsonDirector
  • Tal WenderowDirector
Offering amount
$7M
Amount sold
$7M
Sales commissions
$560K
Placement agents
H.C. Wainwright & Co.
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedJun 2024 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Aileen StockburgerDirector
  • Martin J. MaddenDirector
  • Yoseph BornsteinDirector
  • Tal WenderowDirector
  • Simon SharonExecutive Officer
  • Rachel VakninExecutive Officer
  • Scott BurellDirector
  • Juan Diaz-CartelleExecutive Officer
  • Harel GadotExecutive Officer, Director
  • Prattipati LaxminarainDirector
Offering amount
$1.8M
Amount sold
$1.8M
Sales commissions
$164.5K
Placement agents
H.C. Wainwright & Co.
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJan 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Harel GadotExecutive Officer, Director
  • David Ben NaimExecutive Officer
  • Yoav WaizerDirector
  • Pratipatti LaxminarainDirector
  • Scott BurellDirector
  • Martin MaddenDirector
  • Yoseph BornsteinDirector
Placement agents
H.C. Wainwright & Co., LLC
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJan 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David Ben NaimExecutive Officer
  • Martin MaddenDirector
  • Scott BurellDirector
  • Harel GadotExecutive Officer, Director
  • Yoav WaizerDirector
  • Yoseph BornsteinDirector
  • Pratipatti LaxminarainDirector
Placement agents
H.C. Wainwright & Co., LLC
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJan 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David Ben NaimExecutive Officer
  • Yoav WaizerDirector
  • Yoseph BornsteinDirector
  • Pratipatti LaxminarainDirector
  • Scott BurellDirector
  • Martin MaddenDirector
  • Harel GadotExecutive Officer, Director
Placement agents
H.C. Wainwright & Co., LLC
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facilityglobenewswire.com · Jan 2025

Frequently asked questions

What does Microbot Medical Inc. do?
Microbot Medical develops LIBERTY, a single-use, remotely operated endovascular robotic system that lets physicians perform peripheral vascular procedures from a seated position with remote control. The system is aimed at hospitals and interventional physicians seeking to adopt robotic technology for endovascular care.
Who founded Microbot Medical Inc.?
Microbot Medical Inc. was founded by Moshe Shoham.
Who are Microbot Medical Inc.'s investors?
Microbot Medical Inc.'s investors include Star51 Capital.
How much funding has Microbot Medical Inc. raised?
Microbot Medical Inc. has disclosed $452.6M raised across 7 of its 10 known rounds.
Where is Microbot Medical Inc. headquartered?
Microbot Medical Inc. is headquartered in Braintree, US.